Synthetic biology concept strengthens, shares of biological companies and Zhejiang Zhengyuan hit limit up.

The concept of synthetic biology is gaining strength. As of the time of publication, stocks of biological companies such as Zhejiang Chinyuan have hit the limit up, while stocks of companies like Cansino Biologics and Hongbo Pharmaceutical have risen by more than 5%.